03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Vectibix 100mg : | |
Type | Medicine Authorised |
Originator | Biotech (Vectibix 100mg) |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Amgen |
Responsible Party | Amgen Europe BV |
Origin | The Netherlands |
Manufacturer | Amgen Europe BV |
Origin | The Netherlands |
ATC | L01XC08 |
Revision Date | 01/04/2014 |
Vectibix 100mg :
Vectibix 100mg :
Vectibix 100mg :
Vectibix 100mg :
Vectibix 100mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Vectibix 100mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abscess | Not known |
Acne | Very Common |
Acute kidney injury | Not known |
Alopecia | Very Common |
Anaemia | Very Common |
Anaphylactic reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Uncommon |
Anxiety | Common |
Aphthous ulcer | Common |
Asthenia | Very Common |
Back pain | Very Common |
Blepharitis | Common |
Blood magnesium decreased | Common |
Bronchospasm | Uncommon |
Cellulitis | Common |
Chapped lips | Uncommon |
Cheilitis | Common |
Chest pain | Common |
Chills | Common |
Conjunctivitis | Very Common |
Constipation | Very Common |
Cough | Very Common |
Cyanosis | Uncommon |
Decreased appetite | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Dermatitis | Common |
Dermatitis acneiform | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dry eye | Common |
Dry mouth (Xerostomia) | Common |
Dry skin | Very Common |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Common |
Erythema | Very Common |
Exfoliative rash | Very Common |
Eye infection | Uncommon |
Eye irritation | Common |
Eye pruritus | Common |
Eyelid infection | Uncommon |
Eyelid irritation | Uncommon |
Fatigue | Very Common |
Flushing | Common |
Folliculitis | Common |
Gastrooesophageal reflux disease | Common |
Growth of eyelashes | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Headache | Common |
Hirsutism | Uncommon |
Hyperglycaemia | Common |
Hyperhidrosis | Common |
Hypersensitivity | Common |
Hypertension | Common |
Hypertrichosis | Common |
Hypocalcaemia | Common |
Hypokalaemia | Very Common |
Hypomagnesaemia | Very Common |
Hypophosphataemia | Common |
Hypotension | Common |
Infection | Not known |
Infusion related reaction | Uncommon |
Ingrowing nail | Uncommon |
Insomnia | Very Common |
Interstitial pneumonitis | Not known |
Keratitis | Uncommon |
Lacrimation increased (Epiphora) | Common |
Leucopenia (Leukopenia) | Common |
Lip dry | Uncommon |
Localised infection | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Maculopapular rash | Very Common |
Mucosal inflammation | Very Common |
Nail disorders | Common |
Nasal dryness | Uncommon |
Nausea | Very Common |
Necrotizing fasciitis | Not known |
Ocular hyperaemia | Common |
Oedema peripheral | Very Common |
Onychoclasis | Common |
Onycholysis | Uncommon |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Paronychia | Very Common |
Pruritus | Very Common |
Pulmonary embolism | Common |
Pyrexia | Very Common |
Rash erythematous | Very Common |
Rash generalised | Very Common |
Rash macular | Very Common |
Rash papular | Very Common |
Rash pruritic | Very Common |
Rash pustular | Common |
Rectal haemorrhage | Common |
Scab | Common |
Sepsis (Systemic infection) (Sepsis state) | Not known |
Skin exfoliation (Flaking skin) | Very Common |
Skin fissures | Very Common |
Skin lesion | Very Common |
Skin necrosis | Rare |
Skin rash | Very Common |
Skin reaction | Not known |
Skin toxicity | Very Common |
Skin ulcer | Common |
Stevens-Johnson syndrome | Rare |
Stomatitis | Very Common |
Tachycardia | Common |
Ulcerative keratitis (Ulcer corneal) | Rare |
Urinary tract infection | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Vectibix 100mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Vectibix 100mg MoH 7238 :
Form | Concentrate for solution for infusion |
Packaging | Bottle (Glass) |
Package Size | 1x5ml |
Strength | 100mg |
Storage Condition | 2-8°C Do not freeze |
Public Price | 662081 L.L. |
Stratum | E1 |
NSSF | ✔ |
Quarantine | ✔ |
Reg. Number | 187459/13 |
Submission date | 01/01/2013 |
Registration Year | 2013 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File